Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1053072.RAUwWrV94CrzYsJTxB0lPK7XELbDfsPqu1MC7JAAC9_u0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1053072.RAUwWrV94CrzYsJTxB0lPK7XELbDfsPqu1MC7JAAC9_u0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1053072.RAUwWrV94CrzYsJTxB0lPK7XELbDfsPqu1MC7JAAC9_u0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1053072.RAUwWrV94CrzYsJTxB0lPK7XELbDfsPqu1MC7JAAC9_u0130_provenance.
- NP1053072.RAUwWrV94CrzYsJTxB0lPK7XELbDfsPqu1MC7JAAC9_u0130_assertion description "[As evaluated by MTT assays, gefitinib (EGFR inhibitor) and DIM-C (PPAR? agonist) inhibited growth of 9 bladder cancer cell lines in a dose-dependent manner but with variable sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053072.RAUwWrV94CrzYsJTxB0lPK7XELbDfsPqu1MC7JAAC9_u0130_provenance.
- NP1053072.RAUwWrV94CrzYsJTxB0lPK7XELbDfsPqu1MC7JAAC9_u0130_assertion evidence source_evidence_literature NP1053072.RAUwWrV94CrzYsJTxB0lPK7XELbDfsPqu1MC7JAAC9_u0130_provenance.
- NP1053072.RAUwWrV94CrzYsJTxB0lPK7XELbDfsPqu1MC7JAAC9_u0130_assertion SIO_000772 23409107 NP1053072.RAUwWrV94CrzYsJTxB0lPK7XELbDfsPqu1MC7JAAC9_u0130_provenance.
- NP1053072.RAUwWrV94CrzYsJTxB0lPK7XELbDfsPqu1MC7JAAC9_u0130_assertion wasDerivedFrom befree-2016 NP1053072.RAUwWrV94CrzYsJTxB0lPK7XELbDfsPqu1MC7JAAC9_u0130_provenance.
- NP1053072.RAUwWrV94CrzYsJTxB0lPK7XELbDfsPqu1MC7JAAC9_u0130_assertion wasGeneratedBy ECO_0000203 NP1053072.RAUwWrV94CrzYsJTxB0lPK7XELbDfsPqu1MC7JAAC9_u0130_provenance.
- befree-2016 importedOn "2016-02-19" NP1053072.RAUwWrV94CrzYsJTxB0lPK7XELbDfsPqu1MC7JAAC9_u0130_provenance.